Page last updated: 2024-10-17

n(g),n(g')-dimethyl-l-arginine and Sarcopenia

n(g),n(g')-dimethyl-l-arginine has been researched along with Sarcopenia in 1 studies

N,N-dimethylarginine: asymmetric dimethylarginine; do not confuse with N,N'-dimethylarginine

Sarcopenia: Progressive decline in muscle mass due to aging which results in decreased functional capacity of muscles.

Research Excerpts

ExcerptRelevanceReference
"Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of endothelium nitric oxide synthesis and causes endothelial dysfunction that may be related to sarcopenia."8.31Association between asymmetric dimethylarginine and sarcopenia in community-dwelling older women. ( Fukuo, K; Imamura, T; Otaki, N; Tanino, N; Yano, M; Yokoro, M, 2023)
"Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of endothelium nitric oxide synthesis and causes endothelial dysfunction that may be related to sarcopenia."4.31Association between asymmetric dimethylarginine and sarcopenia in community-dwelling older women. ( Fukuo, K; Imamura, T; Otaki, N; Tanino, N; Yano, M; Yokoro, M, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Yokoro, M1
Otaki, N1
Yano, M1
Imamura, T1
Tanino, N1
Fukuo, K1

Other Studies

1 other study available for n(g),n(g')-dimethyl-l-arginine and Sarcopenia

ArticleYear
Association between asymmetric dimethylarginine and sarcopenia in community-dwelling older women.
    Scientific reports, 2023, 04-04, Volume: 13, Issue:1

    Topics: Aged; Arginine; Female; Humans; Independent Living; Sarcopenia; Vascular Diseases

2023